Australia Stock Exchange release from DIMERIX : Ethics Approval in Australia for Phase 3 COVID-19 Study
22/12/2021 22:16
Australia Stock Exchange release from DIMERIX DXB.AX : Ethics Approval in Australia for Phase 3 COVID-19 Study
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions